The Journal of family practice
-
Comparative Study
Does XR injectable naltrexone prevent relapse as effectively as daily sublingual buprenorphine-naloxone?
YES. MONTHLY EXTENDED-RELEASE INJECTABLE NALTREXONE (XR-NTX) TREATS OPIOID USE DISORDER AS EFFECTIVELY AS DAILY SUBLINGUAL BUPRENORPHINE-NALOXONE (BUP-NX) WITHOUT CAUSING ANY INCREASE IN SERIOUS ADVERSE EVENTS OR FATAL OVERDOSES. (STRENGTH OF RECOMMENDATION: A, 2 GOOD-QUALITY RCTS).
-
A thorough history and physical are key to proper diagnosis and treatment following a patient's encounter with an insect, arachnid, or other arthropod.
-
A diagnosis was arrived at by doing something that the patient's other doctors hadn't: perform a biopsy.
-
The patient had a history of treatment for head lice, but a dermatoscopic exam revealed that lice weren't to blame for his itchy scalp.